AngII has been shown to up-regulate CX3CR1 receptor expression in a human monocyte cell line derived from acute monocytic leukemia patients, indicating its potential regulatory role in blood mononuclear cell activation and migration to inflammation sites (31). Here, AGT is linked to acute monocytic leukemia.